Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
PM's solid fundamentals and commitment to innovation and cost efficiencies position the company well for sustained growth ...
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.
Morgan Stanley analyst Eric Serotta has maintained their bullish stance on PM stock, giving a Buy rating on January 10.Stay Ahead of the ...
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...
Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Moody National Bank Trust Division grew its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by ...
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...